1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Levocarnitine Market predicted to grow exponentially by 2025: Global Market Insights, Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Europe levocarnitine market driven by UK, Germany, France, and Italy may witness moderate growth during forecasted period. Rising cases of renal, arthritis and osteoporosis owing to sedentary lifestyles, rising geriatric population, and increase consumption of fat enhanced diets may trigger the sales of levocarnitine based pharmaceuticals. Levocarnitine based drugs are administered during end stage renal diseases and dialyses which may increase market share.  Asia Pacific levocarnitine market demand led by Japan, China, and India may see a significant growth. Increasing cases of kidney problems owing to changing diet patterns, increased alcohol and fast food intake may stimulate market share. Fatty diets slow down the metabolic rate which propagates the stagnation of toxins in cell walls resulting in chronic kidney problems in the long run. Regional Analysis of Levocarnitine Market :

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Japan has high life expectancy and one of the lowest birth rates globally. According to Forbes magazine, Japan has the lowest population rate in 2018 and by 2065 over 28% of the population will be above the age of 65. Increasing geriatric population in Japan will increase the prevalence of diseases such as Alzheimer’s disease, cardiovascular and osteoporosis issues which may trigger market share. Levocarnitine based pharmaceuticals are administered to induce spatial brain function and regulating metabolic rates thereby driving the demand from their pharmaceutical applications. Regional Analysis of Levocarnitine Market :

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Application Analysis of Levocarnitine Market :  Growing inclusion of levocarnitine in food supplements, health drinks, and medicines owing to changing diet patterns, sedentary lifestyle, and increasing awareness towards timely treatment of common disorders may foster market growth. Increasing prevalence of kidney problems such as urinary tract infections and glomerulonephritis (inflammation of the tiny filters in kidneys) may stimulate levocarnitine market share. In Italy, there was over 1,500 of living and deceased kidney transplants in 2017 indicates growing demand for levocarnitine from kidney health application segment.  Rising demand for functional foods targeted at specific health issues such as kidney, heart, and musculoskeletal system along with growing demand for sport nutrition from athletes and sports persons may contribute to levocarnitine market growth. Increasing cases of osteoporosis with rising geriatric population in developing countries may foster market share. In Australia, over 900 thousand people were suffering with osteoporosis. Levocarnitine is widely used in supplements to increase bone mass and decrease the concentration of fat around joints thereby increasing blood circulation, and lubrication may stimulate market growth.

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Application Analysis of Levocarnitine Market :  Levocarnitine Market size is likely to garner a significant growth over the forecast timeframe as increasing incidences of cardiovascular diseases, anorexia, Rett syndrome, thyroid and diabetes is likely to have positive impact on rising demand for levocarnitine for their application in pharmaceutical industry. Increasing geriatric population base across the globe coupled with rising consumer inclination towards health consciousness may foster levocarnitine market growth.  Levocarnitine (L-Carnitine) is a molecule required for mammalian energy metabolic activities, which removes toxic acyl chemicals from cell walls to maintain healthy metabolic rate. It is an amino acid which can be naturally synthesized within the body and helps the body to produce energy. It facilitates the transfer of long chain fatty acids across mitochondria for beta oxidation and energy production. Loss of levocarnitine is associated with symptoms of myopathy, cardiomyopathy, and hypoglycemia. In UK, over 10% of total population was diagnosed with high blood pressure in 2017. It is widely given to patients with end stage renal diseases to reduce symptoms of hypotension and intradialytic muscle cramps which may foster levocarnitine market share.

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Global levocarnitine market share is consolidated as the market consist of very few pivotal players. Companies such as Northeast Pharmaceutical Group, Biosynth AG, Alfa Aesar, AIDP, Lonza Group, and Ningbo Honor Chemtech are key players in this market. Increasing number of new entrants owing to potential benefits associated with levocarnitine is projected to impact market demand over the projected period. Competitive Market Share of Levocarnitine Market :

7. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Levocarnitine Market @ https://bit.ly/2Y6TcCQhttps://bit.ly/2Y6TcCQ Request for an in-depth table of contents for this report @ https://bit.ly/2M52WuU https://bit.ly/2M52WuU

8. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: